Form 8-K - Current report:
SEC Accession No. 0001193125-25-015713
Filing Date
2025-01-29
Accepted
2025-01-29 16:29:27
Documents
13
Period of Report
2025-01-28
Items
Item 2.05: Cost Associated with Exit or Disposal Activities

Document Format Files

Seq Description Document Type Size
1 8-K d931594d8k.htm   iXBRL 8-K 27854
  Complete submission text file 0001193125-25-015713.txt   155139

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA crgx-20250128.xsd EX-101.SCH 2841
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE crgx-20250128_lab.xml EX-101.LAB 18737
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE crgx-20250128_pre.xml EX-101.PRE 11701
15 EXTRACTED XBRL INSTANCE DOCUMENT d931594d8k_htm.xml XML 3771
Mailing Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070
Business Address 835 INDUSTRIAL ROAD, SUITE 400 SAN CARLOS CA 94070 650-499-8950
CARGO Therapeutics, Inc. (Filer) CIK: 0001966494 (see all company filings)

EIN.: 844080422 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41859 | Film No.: 25569731
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)